Inventor

Vani P. Mocharla

Inventor
Los Angeles, CA, US

Overview

22→
Patents
2000–2021
Patent span
Human necessities
Primary field (CPC A)

Patents· 22 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

A61Kprimary
A61KPreparations for medical, dental or toiletry purposes26%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations19%
C07DHeterocyclic compounds16%
C07CAcyclic or carbocyclic compounds7%
C07KPeptides6%
G01NInvestigating or analysing materials by determining their chemical or physical properties6%
A61JContainers specially adapted for medical or pharmaceutical purposes4%
B65DContainers for storage or transport of articles or materials, e.g. bags, barrels, bottles, boxes, cans, cartons, crates, drums, jars, tanks, hoppers, forwarding containers4%
C07FAcyclic, carbocyclic or heterocyclic compounds containing elements other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur, selenium or tellurium4%
C07BGeneral methods of organic chemistry3%
PatentTitleYear
10,894,807PSMA imaging agents202110,821,196Substrate based PET imaging agents202010,011,632PSMA imaging agents20189,539,349'Formulation, apparatus and method for stabilizing radiopharmaceuticals'20179,539,350'Formulation, apparatus and method for stabilizing radiopharmaceuticals'20179,345,792'Formulation, apparatus and method for stabilizing radiopharmaceuticals'20169,005,577'Substrate based PET imaging agents'20158,932,557'Imaging agents for detecting neurological dysfunction'20158,486,372'Cyclic azapeptides as integrin markers and methods of using'20138,420,052'Imaging agents useful for identifying AD pathology'20138,354,092'Development of molecular imaging probes for carbonic anhydrase-IX using click chemistry'20138,318,132'Imaging agents for detecting neurological dysfunction'20128,293,206'Achievement of a high therapeutic index through molecular imaging guided targeted drug treatment'20128,043,601'Cyclic azapeptides as integrin markers'20117,928,210'Nucleoside based proliferation imaging markers'20117,829,063'Development of molecular imaging probes for carbonic anhydrase-IX using click chemistry'20107,091,240'Tubulin binding ligands and corresponding prodrug constructs'20067,001,926'Tubulin binding agents and corresponding prodrug constructs'20066,956,054'Compositions and methods for use in targeting vascular destruction'20056,593,374'Tubulin binding ligands and corresponding prodrug constructs'20036,350,777'Description anti-mitotic agents which inhibit tubulin polymerization'20026,162,930'Anti-mitotic agents which inhibit tubulin polymerization'2000

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

2000–2006Based in Waco, TX, US· patent location history
2006Based in San Diego, CA, US· patent location history
2010–2016Patents assigned to SIEMENS MEDICAL SOLUTIONS (10)· patent assignee history
2010–2021Based in Los Angeles, CA, US· patent location history
2012–2018Patents assigned to MOCHARLA VANI P (9)· patent assignee history
2012–2018Patents assigned to CHEN GANG (8)· patent assignee history
2012–2018Patents assigned to KASI DHANALAKSHMI (8)· patent assignee history
2012–2018Patents assigned to KOLB HARTMUTH C (8)· patent assignee history
2017–2020Based in Sunnyvale, CA, US· patent location history

Inventor activity

Assignee and location history derived from the patent record.

Assignees
AssigneePatentsSpan
SIEMENS MEDICAL SOLUTIONS102010–2016
MOCHARLA VANI Pself92012–2018
CHEN GANG82012–2018
KASI DHANALAKSHMI82012–2018
KOLB HARTMUTH C82012–2018
Locations
LocationPatentsSpan
Los Angeles, California, US132010–2021
Waco, Texas, US52000–2006
Sunnyvale, California, US32017–2020
San Diego, California, US12006